Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chlorthalidone vs. hydrochlorothiazide in hypertension management: Lessons for guiding clinical practice.

The American journal of the medical sciences·2026
Same author

Annotations from the latest guidelines for hypertension: A mixed bag of takes and mistakes.

The American journal of medicine·2025
Same author

High Heart Rate, Sympathetic Overdrive, and Cardiovascular Risk in Hypertension.

The American journal of cardiology·2025
Same author

Low-Salt Diet <i>and</i> Thiazide Diuretics.

Circulation·2025
Same author

Elevated Plasma Nitrate Levels in Patients with Acute Coronary Syndrome.

The American journal of cardiology·2025
Same author

Effects of Sympathetic Denervation in Metabolism Regulation: A Novel Approach for the Treatment of MASLD?

Cardiology in review·2025

Related Experiment Video

Updated: May 9, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Obesity-Related Hypertension: An Emerging Clinical Phenotype.

Guido Grassi1, Dagmara Hering2, C Venkata S Ram3

  • 1Department of Medicine and Surgery, University Milano-Bicocca, Milan, Italy.

The American Journal of Cardiology
|May 7, 2026
PubMed
Summary

Obesity is a major cardiovascular risk factor, especially when combined with hypertension. This combination accelerates conditions like left ventricular hypertrophy and increases risks for heart disease, arrhythmias, and stroke.

Keywords:
anti-obesity drugsbariatric surgerybody weight reductioncardiovascular eventscardiovascular riskdietary interventionshypertensionlifestyle interventionsobesityobesity-related hypertensionsleep apnea

Related Experiment Videos

Last Updated: May 9, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Area of Science:

  • Cardiology
  • Hypertension Research
  • Obesity Medicine

Background:

  • Obesity is a global pandemic and an independent cardiovascular risk factor.
  • Its impact on cardiovascular outcomes is amplified when co-occurring with hypertension.
  • This phenotype contributes to various pathophysiological changes and clinical complications.

Purpose of the Study:

  • To provide a comprehensive overview of the obesity-related hypertensive phenotype.
  • To detail the pathophysiological mechanisms involved.
  • To discuss clinical consequences and therapeutic strategies.

Main Methods:

  • Literature review and synthesis of existing research.
  • Analysis of pathophysiological pathways.
  • Clinical case study review (implied).

Main Results:

  • Obesity with hypertension exacerbates left ventricular hypertrophy, endothelial dysfunction, and sympathetic activation.
  • It impairs arterial distensibility and promotes pro-atherogenic vascular changes.
  • Leads to kidney dysfunction and increased risk of cardiovascular diseases, arrhythmias, and cerebrovascular events.

Conclusions:

  • The obesity-hypertension phenotype presents significant cardiovascular risks.
  • Understanding its pathophysiology is crucial for effective management.
  • Targeted therapeutic implications are essential for mitigating complications.